Up to 7 years treatment with GLP-1 receptor agonist in patients with type 2 diabetes didn't seem to increase pancreatic cancer risk in a large population-based cohort study.
GLP-1s not linked to suicidal thoughts: Early FDA review beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.
A large retrospective review provided the first cumulative incidence rate of pulmonary aspiration in those undergoing upper endoscopy while receiving popular diabetes and obesity treatments.